Citation: K. Lee et al., G156A MGMT-transduced human mesenchymal stem cells can be selectively enriched by O-6-benzylguanine and BCNU, J HEMATH ST, 10(5), 2001, pp. 691-701
Citation: Js. Reese et al., MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure, J HEMATH ST, 10(1), 2001, pp. 115-123
Authors:
Spiro, TP
Liu, L
Majka, S
Haaga, J
Willson, JKV
Gerson, SL
Citation: Tp. Spiro et al., Temozolomide: The effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O-6-alkylguanine-DNA-alkyltransferase, CLIN CANC R, 7(8), 2001, pp. 2309-2317
Authors:
Liu, L
Spiro, TP
Qin, XS
Majka, S
Haaga, J
Schupp, J
Willson, JKV
Gerson, SL
Citation: L. Liu et al., Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O-6-benzylguanine, CLIN CANC R, 7(8), 2001, pp. 2318-2324
Authors:
Dowlati, A
Haaga, J
Remick, SC
Spiro, TP
Gerson, SL
Liu, LL
Berger, SJ
Berger, NA
Willson, JKV
Citation: A. Dowlati et al., Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation, CLIN CANC R, 7(10), 2001, pp. 2971-2976
Authors:
Zhou, H
Chen, WD
Qin, XS
Lee, K
Liu, LL
Markowitz, SD
Gerson, SL
Citation: H. Zhou et al., MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice, ONCOGENE, 20(42), 2001, pp. 6009-6017
Citation: Js. Reese et al., Overexpression of human O-6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice, ONCOGENE, 20(38), 2001, pp. 5258-5263
Authors:
Taverna, P
Liu, LL
Hwang, HS
Hanson, AJ
Kinsella, TJ
Gerson, SL
Citation: P. Taverna et al., Methoxyamine potentiates DNA single strand breaks and double strand breaksinduced by temozolomide in colon cancer cells, MUT R-DNA R, 485(4), 2001, pp. 269-281
Authors:
Dowlati, A
Hoppel, CL
Ingalls, ST
Majka, S
Li, XL
Sedransk, N
Spiro, T
Gerson, SL
Ivy, P
Remick, SC
Citation: A. Dowlati et al., Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days, J CL ONCOL, 19(8), 2001, pp. 2309-2318
Authors:
Laughlin, MJ
Barker, J
Bambach, B
Koc, ON
Rizzieri, DA
Wagner, JE
Gerson, SL
Lazarus, HM
Cairo, M
Stevens, CE
Rubinstein, P
Kurtzberg, J
Citation: Mj. Laughlin et al., Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors., N ENG J MED, 344(24), 2001, pp. 1815-1822
Authors:
Davis, BM
Encell, LP
Zielske, SP
Christians, FC
Liu, LL
Friebert, SE
Loeb, LA
Gerson, SL
Citation: Bm. Davis et al., Applied molecular evolution of O-6-benzylguanine-resistant DNA alkyltransferases in human hematopoietic cells, P NAS US, 98(9), 2001, pp. 4950-4954
Authors:
Johnsen, AK
France, J
Nagy, N
Askew, D
Abdul-Karim, FW
Gerson, SL
Sy, MS
Harding, CV
Citation: Ak. Johnsen et al., Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence, INT J CANC, 91(3), 2001, pp. 366-372
Authors:
Majumdar, MK
Thiede, MA
Haynesworth, SE
Bruder, SP
Gerson, SL
Citation: Mk. Majumdar et al., Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages, J HEMATH ST, 9(6), 2000, pp. 841-848
Authors:
Koc, ON
Gerson, SL
Cooper, BW
Laughlin, M
Meyerson, H
Kutteh, L
Fox, RM
Szekely, EM
Tainer, N
Lazarus, HM
Citation: On. Koc et al., Randomized cross-over trial of progenitor-cell mobilization: High-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF, J CL ONCOL, 18(9), 2000, pp. 1824-1830
Authors:
Koc, ON
Gerson, SL
Cooper, BW
Dyhouse, SM
Haynesworth, SE
Caplan, AI
Lazarus, HM
Citation: On. Koc et al., Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy, J CL ONCOL, 18(2), 2000, pp. 307-316
Authors:
Taverna, P
Liu, L
Hanson, AJ
Monks, A
Gerson, SL
Citation: P. Taverna et al., Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen, CANC CHEMOT, 46(6), 2000, pp. 507-516
Authors:
Lazarus, HM
Pecora, AL
Shea, TC
Koc, ON
White, JM
Gabriel, DA
Cooper, BW
Gerson, SL
Krieger, M
Sing, AP
Citation: Hm. Lazarus et al., CD34(+) selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome, BONE MAR TR, 25(5), 2000, pp. 559-566
Citation: Xs. Qin et al., Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea, CARCINOGENE, 21(4), 2000, pp. 833-838
Citation: Bm. Davis et al., Limiting numbers of G156A O-6-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection, BLOOD, 95(10), 2000, pp. 3078-3084
Citation: Js. Reese et al., Human mesenchymal stem cells provide stromal support for efficient CD34(+)transduction, J HEMATH ST, 8(5), 1999, pp. 515-523
Citation: Sl. Gerson et al., Leukocyte O-6-akylguanine-DNA alkyltransferase from human donors is uniformly sensitive to O-6-benzylguanine, CLIN CANC R, 5(3), 1999, pp. 521-524
Authors:
Liu, L
Taverna, P
Whitacre, CM
Chatterjee, S
Gerson, SL
Citation: L. Liu et al., Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents, CLIN CANC R, 5(10), 1999, pp. 2908-2917